Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the γ2-subunit of AMP-activated protein kinase

Hasan O. Akman, James N. Sampayo, Fiona A. Ross, John W. Scott, Gregory Wilson, Lee Benson, Claudio Bruno, Sara Shanske, D. Grahame Hardie, Salvatore DiMauro

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

A 10-wk-old infant girl with severe hypertrophy of the septal and atrial walls by cardiac ultrasound, developed progressive ventricular wall thickening and died of aspiration pneumonia at 5 mo of age. Postmortem examination revealed ventricular hypertrophy and massive atrial wall thickening due to glycogen accumulation. A skeletal muscle biopsy showed increased free glycogen and decreased activity of phosphorylase b kinase (PHK). The report of a pathogenic mutation (R531Q) in the gene (PRKAG2) encoding the γ2 subunit of AMP-activated protein kinase (AMPK) in three infants with congenital hypertrophic cardiomyopathy, glycogen storage, and "pseudo PHK deficiency" prompted us to screen this gene in our patient. We found a novel (R384T) heterozygous mutation in PRKAG2, affecting an arginine residue in the N-terminal AMP-binding domain. Like R531Q, this mutation reduces the binding of AMP and ATP to the isolated nucleotide-binding domains, and prevents activation of the heterotrimer by metabolic stress in intact cells. The mutation was not found in DNA from the patient's father, the only available parent, and is likely to have arisen de novo. Our studies confirm that mutations in PRKAG2 can cause fatal infantile cardiomyopathy, often associated with apparent PHK deficiency.

Original languageEnglish
Pages (from-to)499-504
Number of pages6
JournalPediatric Research
Volume62
Issue number4
DOIs
Publication statusPublished - Oct 2007

Fingerprint

Phosphorylase a
Glycogen Storage Disease
AMP-Activated Protein Kinases
Phosphorylase Kinase
Mutation
Glycogen
Adenosine Monophosphate
Hypertrophy
Aspiration Pneumonia
Physiological Stress
Hypertrophic Cardiomyopathy
Cardiomyopathies
Fathers
Genes
Arginine
Autopsy
Skeletal Muscle
Nucleotides
Adenosine Triphosphate
Glycogen Storage Disease Type Ix

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the γ2-subunit of AMP-activated protein kinase. / Akman, Hasan O.; Sampayo, James N.; Ross, Fiona A.; Scott, John W.; Wilson, Gregory; Benson, Lee; Bruno, Claudio; Shanske, Sara; Hardie, D. Grahame; DiMauro, Salvatore.

In: Pediatric Research, Vol. 62, No. 4, 10.2007, p. 499-504.

Research output: Contribution to journalArticle

Akman, HO, Sampayo, JN, Ross, FA, Scott, JW, Wilson, G, Benson, L, Bruno, C, Shanske, S, Hardie, DG & DiMauro, S 2007, 'Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the γ2-subunit of AMP-activated protein kinase', Pediatric Research, vol. 62, no. 4, pp. 499-504. https://doi.org/10.1203/PDR.0b013e3181462b86
Akman, Hasan O. ; Sampayo, James N. ; Ross, Fiona A. ; Scott, John W. ; Wilson, Gregory ; Benson, Lee ; Bruno, Claudio ; Shanske, Sara ; Hardie, D. Grahame ; DiMauro, Salvatore. / Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the γ2-subunit of AMP-activated protein kinase. In: Pediatric Research. 2007 ; Vol. 62, No. 4. pp. 499-504.
@article{58cc2b24d48f42f48a1df6a3163db003,
title = "Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the γ2-subunit of AMP-activated protein kinase",
abstract = "A 10-wk-old infant girl with severe hypertrophy of the septal and atrial walls by cardiac ultrasound, developed progressive ventricular wall thickening and died of aspiration pneumonia at 5 mo of age. Postmortem examination revealed ventricular hypertrophy and massive atrial wall thickening due to glycogen accumulation. A skeletal muscle biopsy showed increased free glycogen and decreased activity of phosphorylase b kinase (PHK). The report of a pathogenic mutation (R531Q) in the gene (PRKAG2) encoding the γ2 subunit of AMP-activated protein kinase (AMPK) in three infants with congenital hypertrophic cardiomyopathy, glycogen storage, and {"}pseudo PHK deficiency{"} prompted us to screen this gene in our patient. We found a novel (R384T) heterozygous mutation in PRKAG2, affecting an arginine residue in the N-terminal AMP-binding domain. Like R531Q, this mutation reduces the binding of AMP and ATP to the isolated nucleotide-binding domains, and prevents activation of the heterotrimer by metabolic stress in intact cells. The mutation was not found in DNA from the patient's father, the only available parent, and is likely to have arisen de novo. Our studies confirm that mutations in PRKAG2 can cause fatal infantile cardiomyopathy, often associated with apparent PHK deficiency.",
author = "Akman, {Hasan O.} and Sampayo, {James N.} and Ross, {Fiona A.} and Scott, {John W.} and Gregory Wilson and Lee Benson and Claudio Bruno and Sara Shanske and Hardie, {D. Grahame} and Salvatore DiMauro",
year = "2007",
month = "10",
doi = "10.1203/PDR.0b013e3181462b86",
language = "English",
volume = "62",
pages = "499--504",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the γ2-subunit of AMP-activated protein kinase

AU - Akman, Hasan O.

AU - Sampayo, James N.

AU - Ross, Fiona A.

AU - Scott, John W.

AU - Wilson, Gregory

AU - Benson, Lee

AU - Bruno, Claudio

AU - Shanske, Sara

AU - Hardie, D. Grahame

AU - DiMauro, Salvatore

PY - 2007/10

Y1 - 2007/10

N2 - A 10-wk-old infant girl with severe hypertrophy of the septal and atrial walls by cardiac ultrasound, developed progressive ventricular wall thickening and died of aspiration pneumonia at 5 mo of age. Postmortem examination revealed ventricular hypertrophy and massive atrial wall thickening due to glycogen accumulation. A skeletal muscle biopsy showed increased free glycogen and decreased activity of phosphorylase b kinase (PHK). The report of a pathogenic mutation (R531Q) in the gene (PRKAG2) encoding the γ2 subunit of AMP-activated protein kinase (AMPK) in three infants with congenital hypertrophic cardiomyopathy, glycogen storage, and "pseudo PHK deficiency" prompted us to screen this gene in our patient. We found a novel (R384T) heterozygous mutation in PRKAG2, affecting an arginine residue in the N-terminal AMP-binding domain. Like R531Q, this mutation reduces the binding of AMP and ATP to the isolated nucleotide-binding domains, and prevents activation of the heterotrimer by metabolic stress in intact cells. The mutation was not found in DNA from the patient's father, the only available parent, and is likely to have arisen de novo. Our studies confirm that mutations in PRKAG2 can cause fatal infantile cardiomyopathy, often associated with apparent PHK deficiency.

AB - A 10-wk-old infant girl with severe hypertrophy of the septal and atrial walls by cardiac ultrasound, developed progressive ventricular wall thickening and died of aspiration pneumonia at 5 mo of age. Postmortem examination revealed ventricular hypertrophy and massive atrial wall thickening due to glycogen accumulation. A skeletal muscle biopsy showed increased free glycogen and decreased activity of phosphorylase b kinase (PHK). The report of a pathogenic mutation (R531Q) in the gene (PRKAG2) encoding the γ2 subunit of AMP-activated protein kinase (AMPK) in three infants with congenital hypertrophic cardiomyopathy, glycogen storage, and "pseudo PHK deficiency" prompted us to screen this gene in our patient. We found a novel (R384T) heterozygous mutation in PRKAG2, affecting an arginine residue in the N-terminal AMP-binding domain. Like R531Q, this mutation reduces the binding of AMP and ATP to the isolated nucleotide-binding domains, and prevents activation of the heterotrimer by metabolic stress in intact cells. The mutation was not found in DNA from the patient's father, the only available parent, and is likely to have arisen de novo. Our studies confirm that mutations in PRKAG2 can cause fatal infantile cardiomyopathy, often associated with apparent PHK deficiency.

UR - http://www.scopus.com/inward/record.url?scp=34748825648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34748825648&partnerID=8YFLogxK

U2 - 10.1203/PDR.0b013e3181462b86

DO - 10.1203/PDR.0b013e3181462b86

M3 - Article

C2 - 17667862

AN - SCOPUS:34748825648

VL - 62

SP - 499

EP - 504

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 4

ER -